Chinese Live Attenuated Hepatitis a Vaccine Freeze-Dried

Chinese Live Attenuated Hepatitis a Vaccine Freeze-Dried, Find details about China Freeze-Dried, Live from Chinese Live Attenuated Hepatitis a Vaccine Freeze-Dried

Pharmaceutical Technology
Chemical Synthesis
Trademark
Biovac-A
Transport Package
Package
Specification
1vial in one pack
Origin
China
Pharmaceutical Technology
Chemical Synthesis
Trademark
Biovac-A
Transport Package
Package
Specification
1vial in one pack
Origin
China

Chinese Live Attenuated Hepatitis a Vaccine Freeze-Dried
Indications

The vaccine is indicated for active immunization against infection caused by HAV in person over age of 18 months.

 

Highlights

•  One shot , lifelong protection, applicable for both child and adult

•  Safety and efficacy had been proven in a 23 year clinical observation in China

•  70% market share in China

•  Marketed in India, Thailand,Uzbekistan, Pakistan, the Philippines, Guatemala and etc;

•  Being registered in Vietnam, Salvador, Honduras, Nicaragua and Dominican Republic

•  Recommended by Indian Academy of Pediatrics (IAP)

•  Complete phase I, II, III, IV Clinical Trial conducted in China

 

Specification

After reconstitution in vial form, each 0.5 ml/dose contains hepatitis A live attenuated vaccine ≥ 6.5 LgCCID50.

 

Dosage Form

Freeze-dried powder for Injection.

 

Route of Administration

Subcutanous Injection

 

Shelf life

24 months.

Highlights

•  One shot , lifelong protection, applicable for both child and adult

•  Safety and efficacy had been proven in a 23 year clinical observation in China

•  70% market share in China

•  Marketed in India, Thailand,Uzbekistan, Pakistan, the Philippines, Guatemala and etc;

•  Being registered in Vietnam, Salvador, Honduras, Nicaragua and Dominican Republic

•  Recommended by Indian Academy of Pediatrics (IAP)

•  Complete phase I, II, III, IV Clinical Trial conducted in China